Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
523.72B | 516.95B | 486.58B | 432.57B | 465.95B | Gross Profit |
88.61B | 76.93B | 91.35B | 90.07B | 93.61B | EBIT |
18.19B | 7.54B | 22.20B | 24.19B | 24.61B | EBITDA |
38.83B | 32.45B | 47.01B | 28.46B | 32.82B | Net Income Common Stockholders |
9.04B | 7.20B | 16.76B | 3.37B | 7.48B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
35.21B | 31.30B | 45.19B | 61.23B | 36.35B | Total Assets |
543.19B | 526.20B | 532.60B | 506.95B | 470.00B | Total Debt |
161.32B | 163.57B | 155.41B | 146.23B | 132.62B | Net Debt |
126.23B | 132.26B | 110.22B | 85.00B | 96.27B | Total Liabilities |
305.10B | 305.44B | 311.69B | 299.85B | 268.81B | Stockholders Equity |
221.26B | 205.47B | 203.09B | 190.71B | 186.28B |
Cash Flow | Free Cash Flow | |||
14.11B | -17.71B | -19.36B | 15.26B | 18.92B | Operating Cash Flow |
38.04B | 695.00M | 1.49B | 41.94B | 48.68B | Investing Cash Flow |
-23.93B | -15.12B | -18.02B | -25.67B | -29.68B | Financing Cash Flow |
-11.05B | 85.00M | -626.00M | 8.19B | -15.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | $208.23B | 3.31 | 21.10% | 4.05% | 10.45% | 873.78% | |
69 Neutral | ¥92.66B | 7.10 | 5.77% | 4.84% | 3.91% | 50.98% | |
69 Neutral | $1.82T | 9.80 | 8.50% | 3.95% | 7.10% | 38.66% | |
65 Neutral | $293.56B | 5.40 | 8.04% | 4.30% | 32.71% | 24.06% | |
65 Neutral | $311.10B | 10.60 | 9.24% | 2.56% | 12.20% | ― | |
49 Neutral | $1.95B | -1.27 | -21.38% | 3.72% | 0.83% | -29.30% | |
31 Underperform | $7.24B | ― | -145.68% | ― | -1.66% | 48.75% |